{"schema_version":"secwatch.filing_event.v1","accession":"0001295947-26-000013","form_type":"8-K","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2026-05-13T20:35:45+00:00","discovered_at":"2026-05-13T20:37:00.603992+00:00","generated_at":"2026-05-13T20:40:20.800641+00:00","sec_items":["1.01","2.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Prestige Consumer reports FY26 adj EPS $4.38; acquires LaCorium Health for $150M","bullets":["FY26 revenue $1,088.7M (-4.3% YoY); adjusted diluted EPS $4.38 vs $4.52 prior year.","Q4 revenue $281.6M (-5% YoY); adjusted diluted EPS $1.23 vs $1.32.","Acquiring LaCorium Health (Australian therapeutic skincare) for ~$150M cash; expected close Q2 FY27.","LaCorium TTM revenue ~$40M; expected ~$12M EBITDA with synergies.","FY27 outlook: organic revenue growth 1-3%, adj EPS $4.42-$4.51, FCF $250M+."],"urls":{"canonical":"https://secwatch.observer/filing/0001295947-26-000013","json":"https://secwatch.observer/filing/0001295947-26-000013.json","markdown":"https://secwatch.observer/filing/0001295947-26-000013.md","text":"https://secwatch.observer/filing/0001295947-26-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000129594726000013/0001295947-26-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000129594726000013/pbh-20260513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T20:40:20.800641+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}